GPER1 and ovarian carcinoma: This hypothesis was supported by others describing the inhibitory role of G-1 regardless of GPER expression in both breast and ovarian cancer cell lines [15], as well as in human ovarian endometriosis stromal [22] and vascular smooth muscle cells [23].